Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank38
3Y CAGR+22.0%
5Y CAGR-6.3%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+22.0%/yr
vs -29.2%/yr prior
5Y CAGR
-6.3%/yr
Recent acceleration
Acceleration
+51.2pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.08+55.8%
20240.05+9.3%
20230.04+6.7%
20220.04-8.9%
20210.05-56.5%
20200.10-18.1%
20190.13-22.7%
20180.16-66.1%
20170.49+28.9%
20160.38-